Russian scientists have developed a vaccine that is expected to be effective against all known variants of the coronavirus, including Delta, Omicron and the PJ.2.1 variant, which the developers call a "supermutant".
The vaccine was developed by specialists at the Gamaleya Centre. The polyvaccine contains antigens from three variants of the virus: the Wuhan strain, Delta and Omicron. According to the developers, this composition should provide protection against various variants of COVID-19.
In addition, its creators expect the vaccine to remain effective against new genetic lineages of the coronavirus that may emerge in the future. Tatyana Grebennikova, head of the molecular diagnostics laboratory at the Gamaleya Centre, told Izvestia that the vaccine is already ready for use.
The developers are now looking for partners to launch mass production of the vaccine.